JP2011522850A5 - - Google Patents

Download PDF

Info

Publication number
JP2011522850A5
JP2011522850A5 JP2011512891A JP2011512891A JP2011522850A5 JP 2011522850 A5 JP2011522850 A5 JP 2011522850A5 JP 2011512891 A JP2011512891 A JP 2011512891A JP 2011512891 A JP2011512891 A JP 2011512891A JP 2011522850 A5 JP2011522850 A5 JP 2011522850A5
Authority
JP
Japan
Prior art keywords
titration
neramexane
weeks
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011512891A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011522850A (ja
JP5923305B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/004184 external-priority patent/WO2009149920A1/en
Publication of JP2011522850A publication Critical patent/JP2011522850A/ja
Publication of JP2011522850A5 publication Critical patent/JP2011522850A5/ja
Application granted granted Critical
Publication of JP5923305B2 publication Critical patent/JP5923305B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011512891A 2008-06-12 2009-06-10 睡眠障害を処置するための１−アミノ−アルキルシクロヘキサン誘導体 Expired - Fee Related JP5923305B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US13178908P 2008-06-12 2008-06-12
EP08010749 2008-06-12
EP08010749.3 2008-06-12
US61/131,789 2008-06-12
PCT/EP2009/004184 WO2009149920A1 (en) 2008-06-12 2009-06-10 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders

Publications (3)

Publication Number Publication Date
JP2011522850A JP2011522850A (ja) 2011-08-04
JP2011522850A5 true JP2011522850A5 (enExample) 2015-10-08
JP5923305B2 JP5923305B2 (ja) 2016-05-24

Family

ID=39721946

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011512891A Expired - Fee Related JP5923305B2 (ja) 2008-06-12 2009-06-10 睡眠障害を処置するための１−アミノ−アルキルシクロヘキサン誘導体

Country Status (15)

Country Link
US (1) US20110207793A1 (enExample)
EP (1) EP2315586A1 (enExample)
JP (1) JP5923305B2 (enExample)
KR (1) KR20110005909A (enExample)
CN (1) CN102026633A (enExample)
AR (1) AR074246A1 (enExample)
AU (1) AU2009256905A1 (enExample)
BR (1) BRPI0911920A2 (enExample)
CA (1) CA2722763A1 (enExample)
IL (1) IL209417A0 (enExample)
MX (1) MX2010013450A (enExample)
RU (1) RU2010154623A (enExample)
TW (1) TW201010691A (enExample)
WO (1) WO2009149920A1 (enExample)
ZA (1) ZA201007763B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2596262T3 (es) * 2007-09-12 2017-01-05 Merz Pharma Gmbh & Co. Kgaa Derivados de 1-amino-alquilciclohexano para su uso en el tratamiento de tinnitus asociado con pérdida de audición
US20110294890A1 (en) * 2010-05-28 2011-12-01 Merz Pharma Gmbh & Co. Kgaa Neramexane for the treatment or prevention of inner ear disorders
JP5978472B2 (ja) * 2014-04-28 2016-08-24 杏林製薬株式会社 耳鳴患者の治療用の薬剤
CN113274365B (zh) * 2021-07-22 2021-10-22 广东科泰鼎润药业科技有限公司 雷美替胺速释缓释双释放制剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19528388A1 (de) * 1995-08-02 1997-02-06 Hans Peter Prof Dr Med Zenner Verwendung von Adamantan-Derivaten zur Behandlung von Erkrankungen des Innenohrs
US6071966A (en) * 1997-06-30 2000-06-06 Merz + Co. Gmbh & Co. 1-amino-alkylcyclohexane NMDA receptor antagonists
DE69814878T2 (de) * 1997-06-30 2004-05-19 Merz Pharma Gmbh & Co. Kgaa 1-amino-alkylcyclohexane als nmda-rezeptor-antagonisten
CN100339070C (zh) * 2002-10-24 2007-09-26 莫茨药物股份两合公司 包含1－氨基环己烷衍生物类和乙酰胆碱酯酶抑制剂类的药物组合物
US20070141148A1 (en) * 2005-11-30 2007-06-21 Merz Pharma Gmbh & Co. Kgaa Neramexane MR matrix tablet
JP2007246507A (ja) * 2006-02-15 2007-09-27 Kracie Seiyaku Kk 疲労の予防・治療組成物及び予防・治療方法
DE102006011922A1 (de) * 2006-03-15 2007-09-20 Uwe Stoldt Mittel zur Behandlung von Tinnitus

Similar Documents

Publication Publication Date Title
NL301202I1 (nl) Linzagolix, of een farmaceutisch aanvaardbaar zout daarvan, zoals linzagolix choline
NO2020038I1 (no) Ozanimod, or a pharmaceutically acceptable salt thereof, including the hydrochloride salt
JP2010501534A5 (enExample)
JP2012072162A5 (enExample)
JP2009537554A5 (enExample)
HRP20171175T1 (hr) Novi triciklički spojevi
WO2011012816A3 (fr) Formulation pharmaceutique
JP2011508438A5 (enExample)
JP2011168603A5 (enExample)
JP2009538861A5 (enExample)
JP2013032389A5 (enExample)
IL250439A0 (en) Use of fingolimod, or a phosphate derivative thereof or a pharmaceutical acceptable salt thereof for the preparation of a drug for the treatment of multiple sclerosis
JP2012522259A5 (enExample)
JP2011518833A5 (enExample)
FR2959935B1 (fr) Forme pharmaceutique orale alcoolo-resistante
JP2013507408A5 (enExample)
MX2010011414A (es) Uso de dronedarona para la preparacion de un medicamento para uso en la prevencion de la hospitalizacion cardiovascular o de la mortalidad.
JP2012502876A5 (enExample)
JP2013532687A5 (enExample)
WO2011009938A3 (en) Stambomycin and derivatives, their production and their use as drugs
WO2011014825A3 (en) Antiangiogenic small molecules and methods of use
JP2011511794A5 (ja) 塩の製造のための方法
JP2011519871A5 (enExample)
EP2666765A3 (en) Process for the preparation of substituted 3-(1-amino-2-methyl-pentane-3-yl)phenyl compounds
JP2011522850A5 (enExample)